ProPhase Labs (PRPH) SEC Filings & 10K Form $0.42 -0.01 (-2.28%) Closing price 07/9/2025 03:59 PM EasternExtended Trading$0.43 +0.00 (+0.45%) As of 07/9/2025 06:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share SEC Filings Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Recent ProPhase Labs SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel DateFilerForm TypeView07/07/20258:04 AMProPhase Labs (Filer)Form DNotice of Exempt Offering of Securities 07/01/20258:00 AMProPhase Labs (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 06/27/20258:00 AMProPhase Labs (Filer)Form 8-K/A06/26/20254:25 PMProPhase Labs (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 06/26/20254:14 PMProPhase Labs (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 06/25/20254:07 PMProPhase Labs (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 06/23/20258:00 AMProPhase Labs (Filer)Form DEF 14A05/20/20257:00 AMProPhase Labs (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 04/30/20254:23 PMProPhase Labs (Filer)Form 10-K/A03/31/20258:53 PMProPhase Labs (Filer)Form NT 10-K03/31/20257:00 AMProPhase Labs (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) Get the Latest News and Ratings for PRPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProPhase Labs and its competitors with MarketBeat's FREE daily newsletter. 03/25/20253:31 PMProPhase Labs (Filer)Form S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans 02/21/20254:15 PMHollenshead Stuart (Reporting)ProPhase Labs (Issuer)Form 4Statement of changes in beneficial ownership of securities 02/21/20254:00 PMHollenshead Stuart (Reporting)ProPhase Labs (Issuer)Form 3Initial statement of beneficial ownership of securities 02/21/20253:30 PMProPhase Labs (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 02/13/20254:00 PMProPhase Labs (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 01/30/20255:27 AMProPhase Labs (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 01/30/20255:05 AMProPhase Labs (Filer)Form 424B501/23/20254:00 PMProPhase Labs (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 12/27/20244:15 PMProPhase Labs (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/20/202411:15 PMProPhase Labs (Filer)Form EFFECT11/13/20243:49 PMProPhase Labs (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 11/13/20243:05 PMProPhase Labs (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 10/18/20244:08 PMProPhase Labs (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 10/04/20244:27 PMProPhase Labs (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 09/26/20244:00 PMProPhase Labs (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/22/20245:07 AMProPhase Labs (Filer)Form 8-K/A08/21/20244:17 PMProPhase Labs (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/14/20247:05 AMProPhase Labs (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/09/20243:30 PMProPhase Labs (Filer)Form NT 10-Q(Data available from 1/1/2016 forward) Related Companies and Tools Related Companies Genenta Science 10K Form VolitionRx 10K Form Anebulo Pharmaceuticals 10K Form Pyxis Oncology 10K Form Adaptimmune Therapeutics 10K Form PyroGenesis Canada 10K Form Verrica Pharmaceuticals 10K Form Connect Biopharma 10K Form Sutro Biopharma 10K Form Ikena Oncology 10K Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:PRPH) was last updated on 7/10/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredHow a Kansas farm boy gained 1,285% in two daysA former farm kid placed a simple trade… and cashed out a 1,285% gain two days later. It wasn’t crypto or a...TradeSmith | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting—or plan to collect—Social Security, this could be a game-changer. A new initiative tie...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProPhase Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProPhase Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
